Therapeutic Effect of Chang'an I Recipe on Irritable Bowel Syndrome With Diarrhea
NCT02822118 · Status: COMPLETED · Phase: PHASE1/PHASE2 · Type: INTERVENTIONAL · Enrollment: 216
Last updated 2016-09-05
Summary
To evaluate the efficacy and safety of TCM decoction Chang'an I Recipe in the treatment of IBS-D. A multicenter, randomized, double-blind, placebo-controlled clinical trial was designed. Patients were applied for central random number and were given corresponding treatment according to inclusion sequences.The treatment group was administered the Chang'an I Recipe, 150ml/bag, 3 times/day; while the control group was administered the placebo, 150ml/bag, 3 times/day. Both courses of treatment were 8 weeks.
Conditions
- Irritable Bowel Syndrome With Diarrhea
Interventions
- DRUG
-
Chang'an I Recipe
Patients in this group were administered the Chang'an I Recipe, 150ml/bag, 3 times/day for 8 weeks.
- DRUG
-
Patients in this group were administered the placebo, 150ml/bag, times/day for 8 weeks.
Sponsors & Collaborators
-
Xiyuan Hospital of China Academy of Chinese Medical Sciences
lead OTHER
Principal Investigators
-
xudong Tang, Ph.D · XiYuan Hospital of China Academy of Traditional Chinese Medicine
Study Design
- Allocation
- RANDOMIZED
- Purpose
- TREATMENT
- Masking
- DOUBLE
- Model
- PARALLEL
Eligibility
- Min Age
- 18 Years
- Max Age
- 70 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2013-01-31
- Primary Completion
- 2015-12-31
- Completion
- 2016-05-31
Countries
- China
Study Locations
More Related Trials
-
Changyanning Tablet for the Treatment of Diarrhea-Predominant Irritable Bowel Syndrome (IBS-D)
NCT05687435 ·Status: UNKNOWN ·Phase: PHASE2/PHASE3
-
Efficacy and Safety of Changkang Granules in the Treatment of Irritable Bowel Syndrome With Predominant Diarrhea (Liver qi Affecting the Spleen Pattern)
NCT06753890 ·Status: NOT_YET_RECRUITING ·Phase: PHASE3
-
A Chinese Herbal Medicine for IBS-C
NCT06319729 ·Status: NOT_YET_RECRUITING ·Phase: PHASE2
-
The Efficacy of Tradition Chinese Medicine in Patients With Irritable Bowel Syndrome
NCT00676975 ·Status: COMPLETED ·Phase: PHASE2
-
Fengliao Changweikang for Diarrhea-predominant Irritable Bowel Syndrome: N-of-1 Trial
NCT07061184 ·Status: NOT_YET_RECRUITING ·Phase: PHASE4
-
A Cross-sectional Study on IBS Subtypes, Chinese Medicine Pattern and Host-gut Microbiota Metabolic Interactions
NCT02822677 ·Status: COMPLETED
-
A Study of Xiang-Sha-Liu-Jun-Zi-Tang in Patients With Irritable Bowel Syndrome
NCT02179580 ·Status: UNKNOWN ·Phase: PHASE2/PHASE3
-
Efficacy and Safety of Modified Gegen Qinlian Decoction for Diarrhea-predominant Irritable Boewl Syndrome
NCT04312477 ·Status: UNKNOWN ·Phase: EARLY_PHASE1
-
The Effect of CanChew® Cannabidiol (CBD) Containing Chewing Gum on Irritable Bowel Syndrome
NCT03003260 ·Status: UNKNOWN ·Phase: NA
-
Efficacy of Low-FODMAPs Dietary Therapy for Irritable Bowel Syndrome in China
NCT03304041 ·Status: COMPLETED ·Phase: NA
-
Study on the Effectiveness and Mechanism of Tong-Xie-Yao-Fang in Treating Diarrhea-predominant Irritable Bowel Syndrome
NCT06737666 ·Status: RECRUITING ·Phase: PHASE1
-
Exploratory Study on Dosage of Qizhi Weitong Granules in the Treatment of Irritable Bowel Syndrome (IBS)
NCT05113888 ·Status: UNKNOWN ·Phase: PHASE2
-
The Effects of Laxative-probiotic Sequential Treatment in the Irritable Bowel Syndrome Patients
NCT02254629 ·Status: COMPLETED ·Phase: PHASE1
-
12-Week Efficacy and Safety Study of Ibodutant in Women With Irritable Bowel Syndrome With Diarrhea (IBS-D)
NCT02320318 ·Status: WITHDRAWN ·Phase: PHASE3
-
A Multi-Strain Probiotic Reduces the Frequency of Diarrhea in IBS-D Patients
NCT05900752 ·Status: COMPLETED ·Phase: NA
-
Acupuncture for Patients With Diarrhea-predominant IBS or Functional Diarrhea: a Randomized Controlled Trial
NCT01350570 ·Status: COMPLETED ·Phase: PHASE2/PHASE3
-
The Efficacy of Herbal Medicine in Relieving Symptoms and Change of Quality of Life of Patients With Irritable Bowel Syndrome (IBS)
NCT00153751 ·Status: COMPLETED ·Phase: PHASE2
-
A Randomized, Double-blind, and Placebo-controlled Study on the Treatments of Irritable Bowel Syndrome
NCT01641224 ·Status: UNKNOWN ·Phase: NA
-
Study on the Molecular Mechanism of Diarrhea-predominant Irritable Bowel Syndrome With Anxiety and Depression Based on Multi-omics Correlation Analysis
NCT05311293 ·Status: UNKNOWN
-
Effect of Acupuncture on Symptoms of Diarrhea and Pain in IBS
NCT00219505 ·Status: TERMINATED ·Phase: NA
-
Efficacy and Safety of DT01 Tablets in Patients With Irritable Bowel Syndrome With Diarrhea
NCT05719896 ·Status: UNKNOWN ·Phase: PHASE2
-
Effects of Open-label vs Double-blind Treatment in IBS
NCT02802241 ·Status: COMPLETED ·Phase: NA
-
Moxibustion for Diarrhea-predominant Irritable Bowel Syndrome
NCT02421627 ·Status: COMPLETED ·Phase: NA
-
Combination Herbal Therapy (CHT) Versus Placebo in Patients With Irritable Bowel Syndrome (IBS)
NCT00130741 ·Status: COMPLETED ·Phase: PHASE1
-
Multicenter Withdrawal Clinical Trials of N-acetyl Glucosamine Capsule for IBS-D Treatment
NCT01893606 ·Status: UNKNOWN ·Phase: PHASE2/PHASE3